These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 22514644)
1. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D. Kim TD; Oh S; Shin S; Janknecht R PLoS One; 2012; 7(4):e34618. PubMed ID: 22514644 [TBL] [Abstract][Full Text] [Related]
2. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression. Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284 [No Abstract] [Full Text] [Related]
3. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
4. Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d. Chandwani R; Fang TC; Dewell S; Tarakhovsky A Front Immunol; 2023; 14():1146699. PubMed ID: 37275914 [TBL] [Abstract][Full Text] [Related]
5. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. Kim TD; Shin S; Berry WL; Oh S; Janknecht R J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899 [TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression. Deng Y; Li M; Zhuo M; Guo P; Chen Q; Mo P; Li W; Yu C J Biol Chem; 2021; 296():100121. PubMed ID: 33434575 [TBL] [Abstract][Full Text] [Related]
7. Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression. Peng K; Zhuo M; Li M; Chen Q; Mo P; Yu C Oncogene; 2020 Nov; 39(47):7076-7091. PubMed ID: 32989255 [TBL] [Abstract][Full Text] [Related]
8. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Ramadoss S; Guo G; Wang CY Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439 [TBL] [Abstract][Full Text] [Related]
9. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases. Li X; Moon G; Shin S; Zhang B; Janknecht R Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482 [TBL] [Abstract][Full Text] [Related]
10. The emerging role of lysine demethylases in DNA damage response: dissecting the recruitment mode of KDM4D/JMJD2D to DNA damage sites. Khoury-Haddad H; Nadar-Ponniah PT; Awwad S; Ayoub N Cell Cycle; 2015; 14(7):950-8. PubMed ID: 25714495 [TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Li W; Zhao L; Zang W; Liu Z; Chen L; Liu T; Xu D; Jia J Biochem Biophys Res Commun; 2011 Dec; 416(3-4):372-8. PubMed ID: 22133676 [TBL] [Abstract][Full Text] [Related]
12. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway. Dong F; Jiang S; Li J; Wang Y; Zhu L; Huang Y; Jiang X; Hu X; Zhou Q; Zhang Z; Bao Z EBioMedicine; 2019 Jan; 39():472-483. PubMed ID: 30527625 [TBL] [Abstract][Full Text] [Related]
13. The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cells. Duan L; Perez RE; Lai X; Chen L; Maki CG J Biol Chem; 2019 Jun; 294(23):9186-9197. PubMed ID: 31036564 [TBL] [Abstract][Full Text] [Related]
14. Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling. Chen Q; Zhuang S; Hong Y; Yang L; Guo P; Mo P; Peng K; Li W; Xiao N; Yu C Oncogene; 2022 Mar; 41(10):1421-1433. PubMed ID: 35027670 [TBL] [Abstract][Full Text] [Related]
15. Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers. Chen Q; Peng K; Mo P; Yu C Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740507 [TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908 [TBL] [Abstract][Full Text] [Related]
17. Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling. Zhuo M; Chen W; Shang S; Guo P; Peng K; Li M; Mo P; Zhang Y; Qiu X; Li W; Yu C Oncogene; 2020 Apr; 39(16):3336-3353. PubMed ID: 32094404 [TBL] [Abstract][Full Text] [Related]
18. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Castellini L; Moon EJ; Razorenova OV; Krieg AJ; von Eyben R; Giaccia AJ Nucleic Acids Res; 2017 Apr; 45(7):3674-3692. PubMed ID: 28073943 [TBL] [Abstract][Full Text] [Related]
19. Crystal structures of two inhibitors in complex with histone lysine demethylase 4D (KDM4D) provide new insights for rational drug design. Wang T; Liu Y; Zhang H; Fang Z; Zhang R; Zhang W; Fan Y; Xiang R Biochem Biophys Res Commun; 2021 May; 554():71-75. PubMed ID: 33780862 [TBL] [Abstract][Full Text] [Related]
20. JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation. Huang X; Zhang S; Qi H; Wang Z; Chen HW; Shao J; Shen J Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2286-95. PubMed ID: 26025680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]